Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tajamul H Mir

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Thrombosis Research|September 23, 2022
"COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting": Classification and possible therapeutic optionsTajamul H Mir
Critical Reviews in Oncology/Hematology|May 3, 2021
Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?Tajamul H Mir
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|February 5, 2021
Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?Tajamul H. Mir
Kidney International|September 24, 2018
The author repliesTajamul H Mir
Kidney International|June 24, 2018
Lipstick obsession and red urineTajamul H Mir, Maina Nisar
Rheumatology (Oxford, England)|January 25, 2021
The beauty and the beast: the butterfly of lupus revisitedTajamul H Mir, Bushra Jabeen
Kidney International|August 22, 2024
Unfair enough: the cosmetic-TIM-kidney syndromesTajamul H Mir, Bushra Jabeen
Blood Vessels, Thrombosis & Hemostasis|September 22, 2025
M protein and the evolving spectrum of platelet-activating anti-PF4 disorders and MGTS and their linkageTajamul H Mir, Rushad Patell, Jason A Freed
Indian Journal of Nephrology|May 17, 2023
Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with COVID-19: A Single Center ExperienceMuzamil Latief, Tajamul H Mir, Mohd L Wani
Clinical and Experimental Pharmacology & Physiology|March 8, 2021
Nicorandil a magic bullet or a double edged sword in critically ill COVID-19 patients?Tajamul H Mir, Parvaiz A Zargar, Bushra Jabeen, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Thrombosis Research|September 23, 2022
"COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting": Classification and possible therapeutic optionsTajamul H Mir
Critical Reviews in Oncology/Hematology|May 3, 2021
Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?Tajamul H Mir
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|February 5, 2021
Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?Tajamul H. Mir
Kidney International|September 24, 2018
The author repliesTajamul H Mir
Kidney International|June 24, 2018
Lipstick obsession and red urineTajamul H Mir, Maina Nisar
Rheumatology (Oxford, England)|January 25, 2021
The beauty and the beast: the butterfly of lupus revisitedTajamul H Mir, Bushra Jabeen
Kidney International|August 22, 2024
Unfair enough: the cosmetic-TIM-kidney syndromesTajamul H Mir, Bushra Jabeen
Blood Vessels, Thrombosis & Hemostasis|September 22, 2025
M protein and the evolving spectrum of platelet-activating anti-PF4 disorders and MGTS and their linkageTajamul H Mir, Rushad Patell, Jason A Freed
Indian Journal of Nephrology|May 17, 2023
Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with COVID-19: A Single Center ExperienceMuzamil Latief, Tajamul H Mir, Mohd L Wani
Clinical and Experimental Pharmacology & Physiology|March 8, 2021
Nicorandil a magic bullet or a double edged sword in critically ill COVID-19 patients?Tajamul H Mir, Parvaiz A Zargar, Bushra Jabeen, et al.
Pageof 3